Precision BioSciences, Inc.
DTIL • NASDAQ
Precision BioSciences, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Michael Amoroso, with a market cap of $170.6M.
Market Cap$170.6M
Employees109.0
CEOMichael Amoroso
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 14, 2026 · in a monthQ1 2026
Financials
Precision BioSciences, Inc. FAQ
Common questions about Precision BioSciences, Inc.
Precision BioSciences, Inc. is scheduled to report earnings for Q1 2026 on May 14, 2026. Analysts estimate revenue of $5.5M.
Precision BioSciences, Inc. has approximately 109 employees.